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The chemistry of derivatives of 3-methyl-1-phenylpyrazol-5-one (Edaravone) 1 has been the subject of much study, as has that of the N-methyl derivative antipyrine, the first truly synthetic pain reliever.
2 Recently, 3 it was claimed that the 4-bromo derivative 1 reacted with ethyl cyanoacetate to produce, as the major product, the "unusual" furanopyrazole 3, supposedly via the intermediacy of the symmetrical compound 2 (Scheme 1). We had reason to question the validity of this claim and now show unambiguously, using X-ray crystallography, that this reaction product is actually the spirocyclic isomer 4. We have resynthesized this compound, 4 which directly furnished crystals suitable for single crystal X-ray structure determination from the crude reaction mixture. The infrared and 1 H NMR spectra matched the reported values. It crystallizes in the monoclinic space group P2 1 /n, with a single molecule in the asymmetric unit.
5 Figure 1 shows a perspective view of the structure, which reveals that it is actually a spiro[(pyrano[2,3-c]pyrazole)-4,4'-pyrazoline], rather than the previously proposed structure. This is a known heterocyclic ring system that has been previously reported in other derivatives of similar pyrazolones. Thus, the two exchangeable protons in the NMR spectrum are associated with the enamino group, rather than imine and hydroxyl protons. In the solid state, one of the NH 2 hydrogens is involved in an intramolecular hydrogen bond to the adjacent ester carbonyl oxygen, while the other participates in an intermolecular hydrogen bond to the spiropyrazolidinone oxygen atom of an adjacent molecule related by a crystallographic centre of inversion. The molecular packing also involves extensive π−π stacking interactions between adjacent molecules. ) to the other pyrazole ring, as expected for a spiro centre. The planes of the Nphenyl rings are inclined to the planes of the attached pyranopyrazole and pyrazoline rings at angles of 6.8 and 25.0 o , respectively. These features and the bond lengths and angles are similar to those in the only other reported Xray crystal structure of this spirocyclic ring system. 7 In retrospect, the formation of this product is not totally unexpected as we have previously demonstrated, 7 as part of a long-standing interest in the chemistry and tautomerism of pyrazolones, 8 that the product of reaction of 3-methyl-1-phenylpyrazol-5-one (5) with TCNE is the related compound 8, rather than the previously proposed isomer 6, formed via the intermediate 7 (Scheme 2). In the present case a related mechanism is likely for formation of 4.
In conclusion, we have shown that the "unusual" major product from the reaction of 4-bromo-3-methyl-1-phenylpyrazol-5-one (1) with ethyl cyanoacetate is actually the spirocyclic compound 4, rather than the previously proposed isomer 3. 
